Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
Pharmacogenomic (PGx) testing is a growing area of personalized medicine with demonstrated clinical utility in improving patient outcomes in oncology. PGx testing of pharmacogenes affecting drug ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...
MedPage Today on MSN
FDA proposes more flexibility in alternatives to animal testing in drug development
Non-animal testing methods could save drugmakers time and money, officials say ...
IVDR: where are we now in molecular testing? How IVDR implementation is progressing in molecular biology laboratories in different European countries IVDR, the new EU legislation for in-vitro ...
WASHINGTON -- Recent advances in systems biology, testing in cells and tissues, and related scientific fields offer the potential to fundamentally change the way chemicals are tested for risks they ...
(MENAFN- EIN Presswire) EINPresswire/ -- The molecular biology service market is experiencing significant expansion, driven by advancements in research and diagnostics. As the demand for precise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results